litlas
ログインアカウント作成

Gideon Bollag

1986–2024 年に発表

73
論文数
29,490
被引用数
65
h 指数
73
i10 指数

被引用数

Gideon Bollag の年別被引用数1961 年: 被引用 1 件1987 年: 被引用 7 件1988 年: 被引用 7 件1989 年: 被引用 7 件1990 年: 被引用 4 件1991 年: 被引用 27 件1992 年: 被引用 44 件1993 年: 被引用 77 件1994 年: 被引用 58 件1995 年: 被引用 50 件1996 年: 被引用 85 件1997 年: 被引用 76 件1998 年: 被引用 79 件1999 年: 被引用 124 件2000 年: 被引用 128 件2001 年: 被引用 143 件2002 年: 被引用 120 件2003 年: 被引用 111 件2004 年: 被引用 85 件2005 年: 被引用 186 件2006 年: 被引用 189 件2007 年: 被引用 204 件2008 年: 被引用 212 件2009 年: 被引用 225 件2010 年: 被引用 373 件2011 年: 被引用 410 件2012 年: 被引用 531 件2013 年: 被引用 553 件2014 年: 被引用 477 件2015 年: 被引用 406 件2016 年: 被引用 362 件2017 年: 被引用 389 件2018 年: 被引用 368 件2019 年: 被引用 823 件2020 年: 被引用 935 件2021 年: 被引用 832 件2022 年: 被引用 631 件2023 年: 被引用 452 件2024 年: 被引用 705 件2025 年: 被引用 305 件2026 年: 被引用 9 件1962〜1986 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,206 件、この内訳の 35.6%中国: 引用元論文 1,092 件、この内訳の 9.2%イギリス: 引用元論文 689 件、この内訳の 5.8%ドイツ: 引用元論文 678 件、この内訳の 5.7%イタリア: 引用元論文 534 件、この内訳の 4.5%フランス: 引用元論文 423 件、この内訳の 3.6%日本: 引用元論文 403 件、この内訳の 3.4%オーストラリア: 引用元論文 338 件、この内訳の 2.9%カナダ: 引用元論文 337 件、この内訳の 2.9%スペイン: 引用元論文 288 件、この内訳の 2.4%オランダ: 引用元論文 277 件、この内訳の 2.4%スイス: 引用元論文 254 件、この内訳の 2.2%
0%35.6%その他 19.4%

機関

分野

  • Biochemistry, Genetics and Molecular Biology46.9%
  • Medicine35.3%
  • Immunology and Microbiology6.1%
  • Neuroscience5.4%
  • Computer Science3.4%
  • Chemistry0.9%
  • その他2%

トピック

  • Melanoma and MAPK Pathways7.3%
  • Protein Kinase Regulation and GTPase Signaling3.8%
  • Computational Drug Discovery Methods3.4%
  • Immune cells in cancer2.4%
  • Cancer Mechanisms and Therapy2.1%
  • PI3K/AKT/mTOR signaling in cancer2%
  • その他79%

共著者

全論文

検索で開く
  1. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model

    著者: Elizabeth E. Spangenberg, Paul Severson, Lindsay A. Hohsfield, Joshua Crapser, Jiazhong Zhang, Elizabeth A. Burton, Ying Zhang, Wayne Spevak, Jack T. Lin, Nicole Phan, Gaston Habets, Andrey Rymar, Garson Tsang, Jason Walters, Marika Nespi, Parmveer Singh, S Broome, Prabha N. Ibrahim, Chao Zhang, Gideon Bollag, Brian L. West, Kim N. Green - Nature Communications 2019 被引用: 998

  2. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

    著者: Scott M. Wilhelm, Christopher Carter, LiYa Tang, Dean Wilkie, Angela McNabola, Hong Rong, Charles Chen, Xiaomei Zhang, Patrick W. Vincent, Mark McHugh, Yichen Cao, Jaleel Shujath, Susan L. Gawlak, Deepa Eveleigh, Bruce R. Rowley, Li Liu, Lila Adnane, Mark Lynch, Daniel Auclair, I Taylor, Rich Gedrich, Andrei Voznesensky, Bernd Riedl, Leonard Post, Gideon Bollag, Pamela A. Trail - Cancer Research 2004 被引用: 4,022

  3. RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF

    著者: Poulikos I. Poulikakos, Chao Zhang, Gideon Bollag, Kevan M. Shokat, Neal Rosen - Nature 2010 被引用: 1,829

  4. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

    著者: Gideon Bollag, Peter Hirth, James Tsai, Jiazhong Zhang, Prabha N. Ibrahim, Hanna Cho, Wayne Spevak, Chao Zhang, Ying Zhang, Gaston Habets, Elizabeth A. Burton, Bernice H. Wong, Garson Tsang, Brian L. West, Ben Powell, Rafe Shellooe, Adhirai Marimuthu, Hoa Nguyen, Kam Y. J. Zhang, Dean R. Artis, Joseph Schlessinger, Fei Su, Brian Higgins, Raman Iyer, Kurt D’Andrea, Astrid Koehler, Michael Stumm, Paul Lin, Richard J. Lee, Joseph F. Grippo, Igor Puzanov, Kevin B. Kim, Antoni Ribas, Grant A. McArthur, Jeffrey A. Sosman, Paul B. Chapman, Keith T. Flaherty, Xiaowei Xu, Katherine L. Nathanson, K. B. Nolop - Nature 2010 被引用: 1,837

  5. Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor

    著者: William D. Tap, Zev A. Wainberg, Stephen P. Anthony, Prabha N. Ibrahim, Chao Zhang, John H. Healey, Bartosz Chmielowski, Arthur P. Staddon, Allen Lee Cohn, Geoffrey I. Shapiro, Vicki L. Keedy, Arun S. Singh, Igor Puzanov, Eunice L. Kwak, Andrew J. Wagner, Daniel D. Von Hoff, Glen J. Weiss, Ramesh K. Ramanathan, Jiazhong Zhang, Gaston Habets, Ying Zhang, Elizabeth A. Burton, Gary C. Visor, Laura Sanftner, Paul Severson, Hoa Nguyen, Marie J. Kim, Adhirai Marimuthu, Garson Tsang, Rafe Shellooe, C. M. Gee, Brian L. West, Peter Hirth, K. B. Nolop, Matt van de Rijn, Henry H. Hsu, Charles Peterfy, Paul Lin, Sandra Tong-Starksen, Gideon Bollag - New England Journal of Medicine 2015 被引用: 582

  6. CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer

    著者: Jingying Xu, Jemima Escamilla, Stephen Mok, John David, Saul J. Priceman, Brian L. West, Gideon Bollag, William H. McBride, Lily Wu - Cancer Research 2013 被引用: 561

  7. Vemurafenib: the first drug approved for BRAF-mutant cancer

    著者: Gideon Bollag, James Tsai, Jiazhong Zhang, Chao Zhang, Prabha N. Ibrahim, K. B. Nolop, Peter Hirth - Nature Reviews Drug Discovery 2012 被引用: 824

  8. Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

    著者: James Tsai, John Tayu Lee, Weiru Wang, Jiazhong Zhang, Hanna Cho, Shumeye Mamo, Ryan Bremer, S. Gillette, Jun Kong, Nikolas K. Haass, Katrin Sproesser, Ling Li, Keiran S.M. Smalley, Daniel W. Fong, Yongliang Zhu, Adhirai Marimuthu, Hoa Nguyen, Billy Lam, Jennifer Liu, Ivana Cheung, Julie Rice, Yoshihisa Suzuki, Catherine A. Luu, Calvin Settachatgul, Rafe Shellooe, John Cantwell, Sung‐Hou Kim, Joseph Schlessinger, Kam Y. J. Zhang, Brian L. West, Ben Powell, Gaston Habets, Chao Zhang, Prabha N. Ibrahim, Peter Hirth, Dean R. Artis, Meenhard Herlyn, Gideon Bollag - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 被引用: 1,346

  9. Inhibition of CSF-1 Receptor Improves the Antitumor Efficacy of Adoptive Cell Transfer Immunotherapy

    著者: Stephen Mok, Richard C. Koya, Christopher Tsui, Jingying Xu, Lídia Robert, Lily Wu, Thomas G. Graeber, Brian L. West, Gideon Bollag, Antoni Ribas - Cancer Research 2013 被引用: 318

  10. Hyperactive Ras in developmental disorders and cancer

    著者: Suzanne Schubbert, Kevin Shannon, Gideon Bollag - Nature reviews. Cancer 2007 被引用: 1,586

  11. Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation

    著者: Debyani Chakravarty, Elmer Santos, Mabel Ryder, Jeffrey A. Knauf, Xiao-Hui Liao, Brian L. West, Gideon Bollag, Richard Kolesnick, Tin Htwe Thin, Neal Rosen, Pat Zanzonico, Steven M. Larson, Samuel Refetoff, Ronald Ghossein, James A. Fagin - Journal of Clinical Investigation 2011 被引用: 387

  12. RAF inhibitors that evade paradoxical MAPK pathway activation

    著者: Chao Zhang, Wayne Spevak, Ying Zhang, Elizabeth A. Burton, Yan Ma, Gaston Habets, Jiazhong Zhang, Jack Lin, Todd Ewing, Bernice Matusow, Garson Tsang, Adhirai Marimuthu, Hanna Cho, Guoxian Wu, Weiru Wang, Daniel W. Fong, Hoa Nguyen, Songyuan Shi, Patrick Womack, Marika Nespi, Rafe Shellooe, Heidi Carias, Ben Powell, Emily Light, Laura Sanftner, Jason Walters, James Tsai, Brian L. West, Gary C. Visor, Hamid Rezaei, Paul Lin, K. B. Nolop, Prabha N. Ibrahim, Peter Hirth, Gideon Bollag - Nature 2015 被引用: 381

  13. Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases

    著者: G.L. Card, B.P. England, Yoshihisa Suzuki, Daniel W. Fong, Ben Powell, Byunghun Lee, Catherine A. Luu, M. Tabrizizad, S. Gillette, Prabha N. Ibrahim, Dean R. Artis, Gideon Bollag, Michael V. Milburn, Sung‐Hou Kim, Joseph Schlessinger, Kam Y. J. Zhang - Structure 2004 被引用: 431

  14. An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling

    著者: Zoi Karoulia, Yang Wu, Tamer A. Ahmed, Qisheng Xin, Julien Bollard, Clemens Krepler, Xuewei Wu, Chao Zhang, Gideon Bollag, Meenhard Herlyn, James A. Fagin, Amaia Lujambio, Evripidis Gavathiotis, Poulikos I. Poulikakos - Cancer Cell 2016 被引用: 213

  15. RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling

    著者: Zhan Yao, Yijun Gao, Wenjing Su, Rona Yaeger, Jessica J. Tao, Na Na, Ying Zhang, Chao Zhang, Andrey Rymar, Anthony Tao, Neilawattie Merna Timaul, Rory Mcgriskin, Nathaniel A. Outmezguine, HuiYong Zhao, Qing Chang, Besnik Qeriqi, Mariano Barbacid, Elisa de Stanchina, David M. Hyman, Gideon Bollag, Neal Rosen - Nature Medicine 2018 被引用: 196

  16. CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy

    著者: Jemima Escamilla, Shiruyeh Schokrpur, Connie Liu, Saul J. Priceman, Diana Moughon, Ziyue Karen Jiang, Frédéric Pouliot, Clara E. Magyar, James L. Sung, Jingying Xu, Gang Deng, Brian L. West, Gideon Bollag, Yves Fradet, Louis Lacombe, Michael E. Jung, Jiaoti Huang, Lily Wu - Cancer Research 2015 被引用: 215

  17. RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

    著者: Fei Su, Amaya Virós, Carla Milagre, Kerstin Trunzer, Gideon Bollag, Olivia Spleiss, Jorge S. Reis‐Filho, Xiangju Kong, Richard C. Koya, Keith T. Flaherty, Paul B. Chapman, Min Jung Kim, Robert Hayward, Matthew J. Martin, Hong Yang, Qiongqing Wang, Holly Hilton, Julie S. Hang, Johannes Noé, Maryou Lambros, Felipe C. Geyer, Nathalie Dhomen, Ion Niculescu‐Duvaz, Alfonso Zambon, Dan Niculescu‐Duvaz, Natasha Preece, Lídia Robert, Nicholas Otte, Stephen Mok, Damien Kee, Yan Ma, Chao Zhang, Gaston Habets, Elizabeth A. Burton, Bernice H. Wong, Hoa Nguyen, Mark Kockx, Luc Andries, Brian Lestini, K. B. Nolop, Richard J. Lee, Andrew K. Joe, James L. Troy, René González, Thomas E. Hutson, Igor Puzanov, Bartosz Chmielowski, Caroline J. Springer, Grant A. McArthur, Jeffrey A. Sosman, Roger S. Lo, Antoni Ribas, Richard Marais - New England Journal of Medicine 2012 被引用: 1,028

  18. MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus

    著者: Peter de Blank, Andrea M. Gross, Srivandana Akshintala, Jaishri O. Blakeley, Gideon Bollag, Ashley Cannon, Eva Dombi, Jason Fangusaro, Bruce D. Gelb, Darren Hargrave, AeRang Kim, Laura J. Klesse, Mignon L. Loh, Staci Martin, Christopher L. Moertel, Roger J. Packer, Jonathan M. Payne, Katherine A. Rauen, Jonathan J. Rios, Nathan Robison, Elizabeth K. Schorry, Kevin Shannon, David A. Stevenson, Elliot Stieglitz, Nicole J. Ullrich, Karin S. Walsh, Brian Weiss, Pamela L. Wolters, Kaleb Yohay, Marielle E. Yohe, Brigitte C. Widemann, Michael J. Fisher - Neuro-Oncology 2022 被引用: 101

  19. Germline KRAS mutations cause Noonan syndrome

    著者: Suzanne Schubbert, Martin Zenker, Sara L. Rowe, Silke Böll, Cornelia Klein, Gideon Bollag, Ineke van der Burgt, Luciana Musante, Vera M. Kalscheuer, Lars‐Erik Wehner, Hoa Nguyen, Brian L. West, Kam Y. J. Zhang, Erik A. Sistermans, Anita Rauch, Charlotte M. Niemeyer, Kevin Shannon, Christian P. Kratz - Nature Genetics 2006 被引用: 740

  20. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21

    著者: George A. Martin, David Viskoohil, Gideon Bollag, Peter C. McCabe, Walter J. Crosier, Heinz Haubruck, Leah Conroy, Robin Clark, P. O’Connell, Richard Cawthon, Michael A. Innis, Frank McCormick - Cell 1990 被引用: 1,003

  21. Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition

    著者: Carlos E. Prada, Edwin Jousma, Tilat A. Rizvi, Jianqiang Wu, R. Scott Dunn, Debra A. Mayes, José A. Cancelas, Eva Dombi, Mi‐Ok Kim, Brian L. West, Gideon Bollag, Nancy Ratner - Acta Neuropathologica 2012 被引用: 142

  22. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells

    著者: Gideon Bollag, D. Wade Clapp, Shane Shih, Felix Adler, You Yan Zhang, Patricia Thompson, Beverly J. Lange, Melvin H. Freedman, Frank McCormick, Tyler Jacks, Kevin Shannon - Nature Genetics 1996 被引用: 608

  23. Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents

    著者: Muling Mao, Feng Tian, John M. Mariadason, Chun C. Tsao, Robert Lemos, Farshid Dayyani, Y.N. Vashisht Gopal, Zhi-Qin Jiang, Ignacio I. Wistuba, Xi Tang, William G. Bornman, Gideon Bollag, Gordon B. Mills, Garth Powis, Jayesh Desai, Gary E. Gallick, Michael A. Davies, Scott Kopetz - Clinical Cancer Research 2012 被引用: 298

  24. A Glutamine Switch Mechanism for Nucleotide Selectivity by Phosphodiesterases

    著者: Kam Y. J. Zhang, G.L. Card, Yoshihisa Suzuki, David Artis, Daniel W. Fong, S. Gillette, Davin Hsieh, Joshua Neiman, Brian L. West, Chao Zhang, Michael V. Milburn, Sung‐Hou Kim, Joseph Schlessinger, Gideon Bollag - Molecular Cell 2004 被引用: 297